Development of drug resistance in a human epidermoid lung carcinoma xenograft line.

[1]  M. Volm,et al.  Occurrence of a multidrug-resistant phenotype in human lung xenografts. , 1987, British Journal of Cancer.

[2]  M. Volm,et al.  Maintenance of morphology and tumour marker production in human epidermoid lung carcinoma xenografts. , 1987, In vivo.

[3]  T. McMillan,et al.  Development of MeCCNU-resistance in clonally derived lines of Lewis lung carcinoma. , 1987, European journal of cancer & clinical oncology.

[4]  F. Schmid,et al.  Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 lines. , 1986, Cancer Research.

[5]  S. Somfai-Relle,et al.  Development and some characteristics of a P388 leukemia strain resistant to 1, 2:5, 6-dianhydrogalactitol. , 1986, European journal of cancer & clinical oncology.

[6]  T. Tsuruo,et al.  Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones. , 1986, Japanese journal of cancer research : Gann.

[7]  N. Bleehen,et al.  Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells. , 1986, British Journal of Cancer.

[8]  T. McMillan,et al.  Development of drug resistance in a murine mammary tumour. , 1985, British Journal of Cancer.

[9]  P. Houghton,et al.  In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered beta-tubulins. , 1985, Cancer research.

[10]  M. Volm,et al.  Growth of human bronchial carcinomas in nude mice. , 1985, British Journal of Cancer.

[11]  G. Steel,et al.  Induced and inherent resistance to alkylating agents in human small-cell bronchial carcinoma xenografts. , 1984, British Journal of Cancer.

[12]  G. Steel,et al.  The therapeutic response of three human tumor lines maintained in immune-suppressed mice. , 1975, Cancer research.

[13]  T. Skovsgaard.  Development of resistance to rubidazone (NSC-164011) in Ehrlich ascites tumor in vivo. , 1975, Cancer chemotherapy reports.

[14]  B. J. Roberts,et al.  Approaches to combination chemotherapy in rat, mouse, and hamster tumors. , 1974, Cancer chemotherapy reports. Part 2.

[15]  K. Danø.  Development of resistance to adriamycin (NSC-123127) in Ehrlich ascites tumor in vivo. , 1972, Cancer chemotherapy reports.

[16]  M. Demerec.  Genetic basis of acquired drug resistance. , 1955, Public health reports.

[17]  M. Volm,et al.  Flow cytometric analysis of primary lung carcinomas and their lymph node metastases. , 1987, Anticancer research.

[18]  W. T. Beck,et al.  Acquisition of multiple drug resistance by CCRF-CEM cells selected for different degrees of resistance to vincristine. , 1984, Cancer treatment reports.

[19]  H. Skipper,et al.  Concepts for controlling drug-resistant tumor cells. , 1980, European journal of cancer.

[20]  F. Schabel,et al.  Patterns of resistance and therapeutic synergism among alkylating agents. , 1978, Antibiotics and chemotherapy.

[21]  F. Schabel.  Nitrosoureas: a review of experimental antitumor activity. , 1976, Cancer treatment reports.

[22]  H. Ford.  Drug Sensitivity. , 1961, The Journal of the College of General Practitioners.